Mitochondrial DNA deletion-dependent podocyte injuries in Mito-miceΔ, a murine model of mitochondrial disease

Shuzo Kaneko1, Joichi Usui1, Masahiro Hagiwara1,2

  • 1Department of Nephrology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.

Experimental Animals
|July 29, 2021
PubMed

Insights

Mitochondrial DNA deletion causes kidney damage, specifically focal segmental glomerulosclerosis (FSGS), by injuring podocytes. This damage is directly linked to the extent of mitochondrial DNA deletion in the kidneys.

Area of Science:

  • Nephrology
  • Mitochondrial Biology
  • Genetics

Background:

  • Focal segmental glomerulosclerosis (FSGS) is a significant kidney complication in human mitochondrial diseases.
  • The precise pathogenesis of FSGS in mitochondrial disease remains incompletely understood.

Purpose of the Study:

  • To investigate the pathogenesis of glomerular injury in mice with mitochondrial DNA deletion (mito-miceΔ).
  • To elucidate the role of mitochondrial dysfunction in the development of renal pathology.

Main Methods:

  • Analysis of biochemical data and kidney histology in mito-miceΔ.
  • Histological examination and immunohistochemistry to assess glomerular and tubular damage.
  • Evaluation of podocyte-related protein expression and podocyte numbers.

Main Results:

  • Proteinuria emerged in mito-miceΔ with approximately 80% mitochondrial DNA deletion, worsening with >90% deletion.
  • Histological analysis revealed FSGS in proteinuric mito-miceΔ.
  • Extensive distal tubular casts and a reduction in podocyte number and related proteins were observed, correlating with proteinuria.

Conclusions:

  • Mitochondrial DNA deletion-induced podocyte injury is the primary mechanism of renal involvement in mito-miceΔ.
  • Podocytes are the main targets of kidney mitochondrial dysfunction stemming from abnormal mitochondrial DNA accumulation.